Skip to main content
Loading

Selecting disease-specific antigens to minimise  ADC toxicity to healthy cells

18 Nov 2024
Antibody Drug Conjugates
Industry Expert
Lars Linden, VP, Therapeutic Antibodies - Bayer Pharmaceuticals
Bayer